A Prospective, Randomized Phase III Study to Compare the Effects of Paclitaxel and Topotecan to Those of Cisplatin and Topotecan for Treatment of Patients With Recurrent and Persistent Cervical Cancer.

Trial Profile

A Prospective, Randomized Phase III Study to Compare the Effects of Paclitaxel and Topotecan to Those of Cisplatin and Topotecan for Treatment of Patients With Recurrent and Persistent Cervical Cancer.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Dec 2013

At a glance

  • Drugs Cisplatin; Paclitaxel; Topotecan
  • Indications Cervical cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms AGO-Zervix-1
  • Most Recent Events

    • 06 Jun 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003652).
    • 11 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 31 Jul 2011 Additional lead trial centres, investigator (Falk Thiel) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top